Jonathan Soslow, MD, MSCI
Professor, Pediatric Cardiology, Co-Director of the Duchenne Muscular Dystrophy Multispecialty Clinic, Director of the Pediatric Gene Therapy Clinic, Vanderbilt University Medical Center
Jonathan Soslow is a Professor of Pediatrics in the Division of Pediatric Cardiology at Vanderbilt University Medical Center. He has advanced training in cardiac imaging, including transthoracic echocardiography, transesophageal echocardiography, and cardiac magnetic resonance imaging (CMR).
His research focuses on the assessment of serum and imaging biomarkers in Duchenne muscular dystrophy (DMD) cardiomyopathy and after heart transplant.
His current funding includes an R01 from the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) to evaluate surrogate outcome measures of DMD cardiomyopathy using machine learning, an R01 from the NIH/NHLBI to evaluate non-invasive markers of heart transplant rejection, an R61/R33 from the NIH/NHLBI to perform a clinical trial using empagliflozin in patients with DMD cardiomyopathy, and two Department of Defense grants to support his DMD research. He is the founder and director of the Duchenne Muscular Dystrophy Cardiovascular Care Consortium.
He is the Director of Clinical Research for the Division of Pediatric Cardiology at Vanderbilt University Medical Center (VUMC). He helped found and now Co-Directs the DMD Multispecialty Clinic at VUMC. He has also helped found and Directs the VUMC Pediatric Gene Therapy Clinic.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.